BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2005
View Archived Issues
Potent and selective CCR3 antagonist DPC-168 from BMS enters phase I
Read More
Antioxidants prevent doxorubicin-induced cardiotoxicity without altering anticancer effect
Read More
GABA-B antagonist exhibits antidepressant effects
Read More
Psoriasin, a newly discovered protein, protects human skin from E. coli infection
Read More
Gene transfer rapidly immunizes mice against anthrax
Read More
Safety data studied for Reminyl
Read More
Enrollment completed in phase III HARS study of Serostim
Read More
TURNS to test Org-24448 for enhancing cognition in schizophrenic patients
Read More
Pharmos receives milestone for Zylet launch
Read More
Helix BioMedix in antiinfectives collaboration with Smith & Nephew
Read More
Sorin completes enrollment in JUPITER II study of Janus Carbostent
Read More
Approval for phase I trial of AL-108 for Alzheimer's
Read More
France requests further information on Exanta for AF
Read More
BioTie inlicenses BKT-104
Read More
Canadian clearance for phase I trial of VP-025 for neuroinflammatory disease
Read More
Schering AG and Novartis enter oncology copromotion agreement for PTK/ZK
Read More
Sulfatides enhance platelet and platelet-leukocyte aggregation
Read More
Peregrine gains access to Merck KGaA's protein expression technology
Read More
Lead antibodies identified under SOA-002 project collaboration
Read More
Teikoku Hormone and Grelan make progress in merger
Read More
Yamanouchi presents novel series of antidiuretic compounds
Read More
Taisho scientists prepare and test agents for obesity
Read More
Kyowa Hakko discloses agents for diabetes and related complications
Read More
New compounds for lipoprotein disorders described in patent literature
Read More
Scientists at Kowa identify PPARalpha agonists for hyperlipidemia, atherosclerosis, etc.
Read More
MAP kinase inhibitors in early development at Ono
Read More
Insulin sensitizers described in a patent
Read More
Cardiac remodeling interrupted, reversed by sildenafil
Read More